Doctors will measure a person’s lymphocyte levels as part of a complete blood count. In this article, we look at different types of lymphocytes, what healthy levels in the blood are, and what ...

A new study published in JCI Insight suggests that interleukin-7 (IL-7), a key immune-boosting cytokine, may help critically ill COVID-19 patients by reducing life-threatening secondary infections.

Iovance's Amtagvi is the first TIL therapy approved by the U.S. Food and Drug Administration (FDA). Its first approved ...

Researchers at Moffitt Cancer Center have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of ...

Researchers have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating ...

Animal studies have shown that sepsis induces extensive lymphocyte apoptosis 1,2,3. Patients who die of sepsis and multiple organ failure have lymphocyte apoptosis in the spleen, intestinal lamina ...

Hu-Mikβ1 was evaluated in a Phase I clinical trial in patients with T-cell large granular lymphocyte leukemia. Hu-Mikβ1 was shown to be safe in Phase I trials; however, no therapeutic efficacy ...

Thus low concentrations of lymphocytes, suppressed natural immunity, suppressed lymphocyte proliferation, and suppressed levels of secretory IgA in saliva are found simultaneously with high levels of ...

Each lymphocyte produces its own specific receptor that corresponds to a specific antigen. When a lymphocyte encounters that antigen it multiplies, creating large numbers of identical lymphocytes ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the "Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...